Hematopoiesis News Volume 13.07 | Feb 22 2022

    0
    27







    2022-2-22 | HN 13.07


    Hematopoiesis News by STEMCELL Technologies
    Vol. 13.07 – 22 February, 2022
    TOP STORY

    Inhibition of LDHA to Induce EEF2 Release Enhances Thrombocytopoiesis

    Researchers found that megakaryocyte/platelet-specific lactate dehydrogenase A (LdhA)-knockout mice showed an increased number of platelets with remarkably accelerated megakaryocyte maturation and proplatelet formation.
    [Blood]

    Abstract
    Request your free copy of the 'Production of Chimeric Antigen Receptor T Cells' Wallchart
    PUBLICATIONSRanked by the impact factor of the journal

    Selective Targeting of Multiple Myeloma Cells with a Monoclonal Antibody Recognizing the Ubiquitous Protein CD98 Heavy Chain

    Scientists reported that multiple myeloma, an incurable hematological malignancy, could be specifically targeted by a monoclonal antibody that recognized a ubiquitously present protein, CD98 heavy chain.
    [Science Translational Medicine]

    AbstractPress Release

    The Role of the Atypical Chemokine Receptor CCRL2 in Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia

    Investigators revealed that CCRL2 was up-regulated in primitive cells from patients with myelodysplastic syndrome and secondary AML.
    [Science Advances]

    Full Article

    Multi-Omics Reveals Mitochondrial Metabolism Proteins Susceptible for Drug Discovery in AML

    To interrogate the effect of protein expression alterations in AML, researchers performed a quantitative mass spectrometry in parallel with RNAseq analysis using AML mouse models.
    [Leukemia]

    Full Article

    Targeting the NOTCH1-MYC-CD44 Axis in Leukemia-Initiating Cells in T-ALL

    Secondary transplantation from PDX and ΔPTEN models of T-cell acute lymphoblastic leukemia (T-ALL), confirmed delayed leukemia development and extended survival of mice engrafted with T-ALL from ARV-825 treated mice, providing functional confirmation of depletion of leukemia-initiating cells.
    [Leukemia]

    Full Article

    NAD+ Depletion Enhances Reovirus-Induced Oncolysis in Multiple Myeloma

    The combination of reovirus and NAD+ depletion achieved greater antitumor effects in KMS12 tumors in vivo and patient-derived CD138+ multiple myeloma cells.
    [Molecular Therapy Oncolytics]

    AbstractFull ArticleGraphical Abstract

    Hematopoietic Stem and Progenitor Cells Improve Survival from Sepsis by Boosting Immunomodulatory Cells

    The authors hypothesized that the inflammatory environment of Group A Streptococcus infection drove rapid hematopoietic stem and progenitor cell (HSPC) differentiation and depletion that could be rescued by infusion of donor HSPCs.
    [eLife]

    Full Article

    Glycosphingolipid-Glycan Signatures of Acute Myeloid Leukemia Cell Lines Reflect Hematopoietic Differentiation

    Investigators performed an in-depth glycosphingolipid (GSL) glycan analysis of 19 AML cell lines using porous graphitized carbon liquid chromatography-mass spectrometry revealing strikingly different GSL glycan profiles between the various AML cell lines.
    [Journal of Proteome Research]

    Full ArticleGraphical Abstract

    Raised SPINK1 Levels Play a Role in Angiogenesis and the Transendothelial Migration of ALL Cells

    In a co-culture system of human umbilical vein endothelial cells and acute lymphoblastic leukemia (ALL) cells, serine protease inhibitor Kazal type 1 (SPINK1) exposure resulted in enhanced endothelial cell motility and ALL cells trans-endothelial migration.
    [Scientific Reports]

    Full Article

    A Randomized Double-Blind Placebo-Controlled Clinical Trial of Oral Hydroxyurea for Transfusion-Dependent β-Thalassaemia

    Researchers conducted a randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of hydroxyurea in transfusion-dependent β-thalassaemia.
    [Scientific Reports]

    Full Article
    Return to your lab safely and efficiently with these guides and resources so that you can focus more on moving your research goals forward.
    REVIEWS

    Delivery Strategies in Treatments of Leukemia

    Scientists discuss available FDA-approved anti-leukemia drugs and therapies with a focus on the advances in the development of anti-leukemia drug delivery systems.
    [Chemical Society Reviews]

    AbstractGraphical Abstract

    The Contributory Roles of the CXCL12/CXCR4/CXCR7 Axis in Normal and Malignant Hematopoiesis: A Possible Therapeutic Target in Hematologic Malignancies

    The authors discuss how aberrant expression of C-X-C motif chemokine 12 (CXCL12)/C-X-C chemokine receptor type 4 (CXCR4) and CXCL12/CXCR7 pathways might regulate leukemogenesis and end by outlining the key news of preclinical and clinical investigations in leukemia treatment.
    [European Journal of Pharmacology]

    AbstractGraphical Abstract
    INDUSTRY AND POLICY NEWS

    BeiGene Announces US FDA Acceptance of Supplemental New Drug Application for BRUKINSA (zanubrutinib) in Chronic Lymphocytic Leukemia

    BeiGene announced that the US FDA has accepted a supplemental new drug application or BRUKINSA® for the treatment of adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.
    [BeiGene]

    Press Release

    Elsa U. Pardee Foundation and National Cancer Institute Fund Leukemia Research at TTUHSC El Paso

    Texas Tech University Health Sciences Center (TTUHSC) El Paso has received more than a quarter-million dollars to study the proteins that contribute to disease progression and drug resistance in AML and chronic myeloid leukemia.
    [El Paso Herald-Post]

    Press Release
    FEATURED EVENT

    Metabolites in Signaling and Disease

    April 3 – April 5
    Lisbon, Portugal

    > See All Events

    JOB OPPORTUNITIES

    Researcher – Cancer Biology

    BC Cancer Research Institute – Vancouver, British Columbia, Canada

    Postdoctoral Scientist – Cellular Immunology/T Cell Therapy

    TU Dresden – Dresden, Germany

    Postdoctoral Research Fellow – Virology

    George Mason University – Prince William, Virginia, United States

    Postdoctoral Position – Regenerative Medicine

    Stanford University – Stanford, California, United States

    Postdoctoral Scholar – Pediatric Hematology

    Penn State College of Medicine – Hershey, Pennsylvania, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Hematopoiesis News Twitter